VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1650223
Sex: F
Age:
State: FL

Vax Date: 03/25/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: 2 weeks from vaccine large blister on big toe, tiny blisters on right toes; pins and needles; red dots on both feet; rash & hives whole body, pins & needles; rash & hives whole body, pins & needles; chills; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received BNT162b2 (PFIZER- BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER2613) dose 1 via an unspecified route of administration, administered in the right arm on 25Mar2021 15:30 as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, fibromyalgia and allergy to sulfa. Concomitant medications included methotrexate, celecoxib (CELEBREX), metoprolol and duloxetine. The patient did not receive any other vaccine within 4 weeks. The patient did not have COVID-19 prior to vaccination. The patient did not test positive for COVID-19 after vaccination. Exactly 1 week after the vaccine on 01Apr2021 at 19:00, the patient experienced red dots on both feet, rash and hives whole body, pins and needles, chills. Two weeks after the vaccine, the patient had a large blister on big toe, tiny blisters on right toes. This resulted in a Doctor or other healthcare professional office/clinic visit. The patient was treated with an injection of Solu Medrol. The outcome of red dots on both feet, rash and hives whole body, pins and needles, chills, blisters was not recovered.

Other Meds: METHOTREXATE; CELEBREX; METOPROLOL; DULOXETINE

Current Illness:

ID: 1650224
Sex: F
Age:
State: SC

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Burning in the throat; Throwing up; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14Apr2021 at 11:15 (at the age of 56-year-old) as a single dose for COVID-19 immunization. Medical history was not reported. Concomitant medications included cetirizine hydrochloride (ZYRTEC), bupropion hydrochloride (WELLBUTRIN), (estradiol) ESTRACE and (apremilast) OTEZLA, all since unknown date and unknown indication. The patient previously took sulfur and experienced allergy to it. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 14:00, the patient experienced burning in the throat, and throwing up. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events burning in the throat and throwing up was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; WELLBUTRIN; ESTRACE; OTEZLA

Current Illness:

ID: 1650225
Sex: M
Age:
State: NM

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210415; Test Name: Body temperature; Result Unstructured Data: Test Result:100.1 (unspecified unit); Comments: Low grade fever (100.1)

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: body aches; Low grade fever (100.1); head ache; This is a spontaneous report from a contactable consumer, the patient. A 27-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Apr2021 at 11:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation.. The patient had no medical history reported. The patient had no known allergies. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Mar2021 at 10:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, at 05:00 the patient experienced low grade fever (100.1), body aches and head ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events of low-grade fever (100.1), body aches and head ache were not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650226
Sex: F
Age:
State: AL

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Numbness/tingling sensation in left arm; Reduction of motor skills in left arm; Occasional mild pain; Numbness/tingling sensation in leftarm; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 05Apr2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any concomitant medications. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm left on 15Mar2021 at 14:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 17:00 the patient experienced numbness/tingling sensation in left arm, occasional mild pain and reduction of motor skills in left arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events numbness/tingling sensation in left arm, occasional mild pain and reduction of motor skills in left arm was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650227
Sex: F
Age:
State: MA

Vax Date: 03/25/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210326; Test Name: SARS-CoV-2-test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Shingles rash on left shoulder blade; Rash on left shoulder blade; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergies and allergy to sulfa drugs. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) from an unknown start date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had been tested for COVID-19. On 26Mar2021, the patient underwent Sars-CoV-2 test and the result was negative. On 31Mar2021, the patient experienced shingles rash on left shoulder blade. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the events shingles rash on left shoulder blade was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1650228
Sex: F
Age:
State:

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Very sore arm; Overall tiredness; Feeling sluggish; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 14Apr2021 at 11:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included multiple sclerosis. The patient previously took amoxicillin (MANUFACTURER UNKNOWN), VICODIN and PERCOCET on an unknown date and experienced allergy. The patient's concomitant medications included interferon beta-1a (REBIF) and also birth control (unspecified) for unknown indications from an unknown start date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 24Mar2021 at 11:00 as a single dose for COVID-19 immunisation. On 15Apr2021 at 08:00, the patient had experienced very sore arm, overall tiredness and feeling sluggish. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the events, very sore arm, overall tiredness and feeling sluggish was recovering at the time of this report. No follow-up attempts are possible. Information about lot number cannot be obtained.

Other Meds: REBIF

Current Illness:

ID: 1650229
Sex: M
Age:
State: FL

Vax Date: 03/05/2021
Onset Date: 03/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: 3 days after the vaccine I got shingles; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 05Mar2021 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included heart issues from an unknown date. The patient did not receive any medications within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Mar2021, three days after vaccination, the patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event, shingles which included treatment with steroids and anti-viral medications. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was resolved with sequelae at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650230
Sex: M
Age:
State:

Vax Date: 01/02/2021
Onset Date: 04/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Tinnitus in both ears; This is a spontaneous report from a non-contactable healthcare professional. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via intramuscular route of administration in the left arm on 02Jan2021 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via intramuscular route of administration in the left arm on 17Dec2020 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, the patient experienced tinnitus in both ears which started in the left then moved to the right, it was manageable but annoying. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the event and included treatment with Zyrtec and Tylenol. The clinical outcome of the event tinnitus in both ears was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650231
Sex: F
Age:
State: CO

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Body aches; Fatigue; Headache; Chills; Fever; Redness, pain and swelling at injection site; Redness, pain and swelling at injection site; Redness, pain and swelling at injection site; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included levothyroxine (MANUFACTURER UNKNOWN) and loratadine (CLARITIN) from unknown date for unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 09:00, the patient experienced redness, pain and swelling at injection site; fever; chills; headache; body aches; fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events redness, pain and swelling at injection site; fever; chills; headache; body aches; fatigue was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; CLARITIN [LORATADINE]

Current Illness:

ID: 1650232
Sex: F
Age:
State: MO

Vax Date: 03/21/2021
Onset Date: 03/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Painful sores (Psoriasis like) inside mouth; Painful sores (Psoriasis like) inside mouth; Painful sores (Psoriasis like) on tongue.; Painful sores (Psoriasis like) on tongue.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) in the right arm on 21Mar2021 at 18:00 (at the age of 61-years-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) in the left arm on 11Apr2021 at 18:00 (at the age of 61-years-old); both as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa drugs. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) , ezetimibe (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN); all for unspecified indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, the patient experienced painful sores (Psoriasis like) inside mouth and on tongue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event painful sores (Psoriasis like) inside mouth and on tongue was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: GABAPENTIN; LISINOPRIL; EZETIMIBE; LEVOTHYROXINE

Current Illness:

ID: 1650233
Sex: M
Age:
State: FL

Vax Date: 03/29/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: red spots appeared on the the left inner elbowwith no pain; dark red bruise appeared on theside of right elbow; Pain started on the rightside arm with light red patch; This is a spontaneous report from a contactable consumer. A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER 8730) via an unspecified route of administration in the arm left on 29Mar2021 at 14:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included betamethasone sodium phosphate (BETAMETHASONE) and beclometasone dipropionate (MANUFACTURER UNKNOWN) both on an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11th April, the patient experienced pain on the right side of arm with light red patch. On 12th April, dark red bruise appeared on the side of right elbow. The patient felt pain on the side arm and elbow while stretching the hand or pressing the red patch. On 15th April, red spots appeared on the the left inner elbow with no pain. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the event pain started on the right side arm with light red patch, event dark red bruise appeared on the side of right elbow and red spots appeared on the the left inner elbow with no pain was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BETAMETHASONE; BECLOMETASONE DIPROPIONATE

Current Illness:

ID: 1650234
Sex: F
Age:
State: OH

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Little tenderness at injection sight (1-2 days); The initial case was missing the following minimum criteria: Unspecified AE. Upon receipt of follow-up information on (04Aug2021), this case now contains all required information to considered valid. This is a spontaneous report from a contactable consumer. A 72-year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in Arm at the age of 72 years old on 25Feb2021 08:00 (Batch/Lot Number: EN6203; Expiration Date: 30Jun2021) as dose 2, single for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 Intramuscular administered in upper arm on 31Jan2021 at 09:15 am (Batch/Lot Number: EL9265; Expiration Date: 31Feb2021) at the age of 72 years old for COVID-19 immunisation. The patient experienced little tenderness at injection site (1-2 days) on an unspecified date. The patient stated that she is having open heart surgery and is concern about the Pfizer vaccine protection being compromised by the surgical procedure. The outcome of the event was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650235
Sex: F
Age:
State: NJ

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Total body aches; Injection site pain; Fatigue; Chills; Feverish; Headache; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroid and moderate eczema. Concomitant medications included norethisterone acetate, ethinylestradiol (AUROVELA 1/20), levothyroxine (MANUFACTURER UNKNOWN), betamethasone (BETAMETHA), mupirocin calcium (MUPIR) and macrogol, propylene glycol, simeticone, sorbic acid, sorbitol, white soft paraffin (VANICREAM); all for unspecified indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EP6955) via an unspecified route of administration in the left arm on 25Mar2021 at 10.30, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no allergies to medications, food or other products. On 14Apr2021 at 21:00, the patient experienced total body aches, injection site pain, fatigue, chills, feverish and headache. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were taken as a result of events total body aches, injection site pain, fatigue, chills, feverish and headache and included treatment with tylenol. The clinical outcome of the events total body aches, injection site pain, fatigue, chills, feverish and headache was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AUROVELA 1/20; LEVOTHYROXINE; BETAMETHA; MUPIR; VANICREAM

Current Illness:

ID: 1650236
Sex: M
Age:
State: TX

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Chest pressure; Episodess of sob, chest pressure, and tiredness that started the day after 2nd injection and has continued every 2 or 3 day since last episode was 4/14 during the night.; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm right on 18Mar2021 at 13:15 hours (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and diabetes. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and metformin hydrochloride (METFORMIN) from unknown date and for unknown indications. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm right on 25feb2021 at 13:15 hours (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 09:00, the patient experienced episodes of shortness of breath, chest pressure, and tiredness that started the day after 2nd injection and has continued every 2 or 3 day since last episode was 14Apr2021 during the night. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events shortness of breath, chest pressure, and tiredness was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN; METFORMIN

Current Illness:

ID: 1650237
Sex: F
Age:
State: OH

Vax Date: 03/26/2021
Onset Date: 03/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210328; Test Name: Blood pressure; Result Unstructured Data: Test Result:went above normal

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Blood pressure also went above normal; heart burn; sleeplessness; hungry; tiredness; could not concentrate; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 44-years-old Non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), second dose via an unspecified route of administration, administered in Arm Left on 26Mar2021 18:30 (at the age of 44 years) as single for covid-19 immunization. Medical history included I am Diabetic from an unknown date and unknown if ongoing. There were no concomitant medications. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), first dose via an unspecified route of administration, administered in Arm Left on 05Mar2021 18:30 (at the age of 44 years) as single for covid-19 immunization. Patient did not have any known allergies. Patient did not have COVID prior vaccination and was not tested post vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other medications in two weeks. On 28Mar2021 21:00 the patient experienced heart burn and sleeplessness from next 2 days of second dose. Patient started to feel hungry and heartburn and could not sleep for 10 days from there. Patient was also feeling so tiredness and could not concentrate and Blood pressure also went above normal. Adverse Events resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included blood pressure measurement which went above normal on 28Mar2021. Adverse Event was treated by Doctor who suggested to use sleep aid like Benadryl. The outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650238
Sex: F
Age:
State: NM

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210412; Test Name: heart beat; Result Unstructured Data: Test Result:irregular

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: fatigue; red clear liquid drainage from one nostril; sneezing; gum numbness; eye twitching; jaw pain; itchy; joint pain; sinus burning; ear ache; red ears; bloody nose; aerobic onset asthma; irregular heart beat; head ache; stuffy; swelling; Hives; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received bnt162b2 (BNT162B2; Batch/Lot Number: EWO150), via an unspecified route of administration, administered in left arm, on 08Apr2021 at 11:00 (at the age of 34 years old) as dose 1, single for COVID-19 immunisation. Medical history included known allergies to penicillin. The patient was not pregnant at the time of vaccination. Concomitant medication(s) included doxycycline 20 mg; and, probiotics, both were taken for an unspecified indication, start and stop date were not reported. The patient was also taking vitamins. The patient did not receive other vaccines in four weeks. On 08Apr2021 1st day, it was reported that the patient experienced hives, swelling, headache and stuffy (medically significant). On 3rd day (12Apr2021), the patient experienced aerobic onset asthma with irregular heartbeat with exercise, and stuffy (medically significant). On 5th day (14Apr2021), the patient experienced headache, earache, red ears, itchy, joint pain, jaw pain, gum numbness, bloody nose plus sinus burning and eye twitching (medically significant). On 7th day (16Apr2021), the patient experienced red clear liquid drainage from one nostril, headache, sinus burning, sneezing, joint pain and fatigue (medically significant). The patient received steroid shot, prednisone rx and loratadine rx as treatments for the events. The patient did not have COVID prior vaccination and was not tested for COVID pot-vaccination. The outcome of the events was recovering.

Other Meds: DOXYCYCLINE; PROBIOTICS

Current Illness:

ID: 1650239
Sex: F
Age:
State: CO

Vax Date: 03/22/2021
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: I experienced a painful knot in theright arm muscle where the COVIDvaccine was injected.; lost strength in right arm; I experience pain when I getdressed, and do simple things likereach for a dish from the cabinet.; the pain when I use that arm is now in my shoulder.; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the right arm on 22Mar2021(at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. The patient had previously taken penicillin and experienced penicillin allergy. Concomitant medications included vitamins and immune support supplement both from an unknown date for unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 01Mar2021(at the age of 70-years-old) as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021, the patient experienced painful knot in the right arm muscle where the COVID vaccine was injected. The patient lost strength in her right arm, which continued to be weak. The patient experienced pain when she got dressed, and while doing simple things like reach for a dish from the cabinet and the pain when she used that arm was in her shoulder. No therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events painful knot in the right arm muscle where the COVID vaccine was injected, lost strength in her right arm, which continued to be weak, pain when she got dressed, and while doing simple things like reach for a dish from the cabinet and the pain when she used that arm was in her shoulder was resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650240
Sex: M
Age:
State: NC

Vax Date: 03/05/2021
Onset Date: 03/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: muscles are very sore; can not sleep; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6205) via an unspecified route of administration in the right arm on 05Mar2021 at 13:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Mar2021, the patient experienced muscles are very sore and cannot sleep. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events. The clinical outcome for the events muscle soreness and insomnia were not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650241
Sex: F
Age:
State: MI

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Broke out in hives all over stomach; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 14Apr2021 at 12:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Patient had no known allergies to food, medication or other products. Concomitant medications included ibuprofen sodium (IBUPROFEN) from an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 09:15, the patient experienced broke out in hives all over stomach. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event broke out in hives all over stomach was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1650242
Sex: F
Age:
State: TX

Vax Date: 03/18/2021
Onset Date: 03/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20201215; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Hair loss; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number UNKNOWN) via an unspecified route of administration on 18Mar2021 at 11:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included COPD (chronic obstructive pulmonary disease). The patient had no known allergies to food, medication or other products. Concomitant medications included fluticasone propionate; salmeterol xinafoate (ADVAIR) and vitamin s (MANUFACTURER UNKNOWN); for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had been tested for COVID-19. On 15Dec2020, the patient underwent SARS-CoV-2 test as nasal swab and the result was negative. On 22Mar2021, the patient experienced hair loss. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event hair loss and included treatment with unspecified medication from an unknown date. The clinical outcome of the event hair loss was not resolved, at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ADVAIR

Current Illness:

ID: 1650243
Sex: M
Age:
State: OH

Vax Date: 03/31/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Currently have a change in my taste; Change in smell-Some things smell rancidor like rubbing alcohol, any type of cleaning/soap products like Lysol cleaning agent all smell exactly the same; Cookies, soup, sun butter, pretzel and certain chips also have the same terrible taste.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine, kidney stones and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19.The patient did not have any known allergies to food, medications or other products. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) for unspecified indication started from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced change in the taste and smell. Some things smell rancid or like rubbing alcohol and any type of cleaning/soap products like Lysol cleaning agent, all smell exactly the same. Cookies, soup, sun butter, pretzel and certain chips also had the same terrible taste. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events change in the taste and smell and cookies, soup, sun butter, pretzel and certain chips also had the same terrible taste was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: GABAPENTIN

Current Illness:

ID: 1650244
Sex: F
Age:
State: OH

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: 'My' face felt numb; Tingly from upper lip down into 'my' jaw and neck; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 09:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient reported medical history which included hypothyroidism, high blood pressure (BP), anxiety, depression, allergies, and known allergy to amoxicillin. Concomitant medications included gliclazide (CLARITIN), levothyroxine sodium (SYNTHROID), buspirone (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and hydrochlorothiazide, lisinopril (LISINOPRID) for an unknown indication since an unspecified date and is unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 24Mar2021 at 09:00 as a single dose for COVID-19 immunisation. On 14Apr2021 at 09:30 the patient's face felt numb/tingly from upper lip down into jaw and neck. This happened approximately 20 minutes after injection. The patient did not receive any treatment for the events of face felt numb/tingly from upper lip down into jaw and neck. The clinical outcome of the events 'My' face felt numb and tingly from upper lip down into 'my' jaw and neck was resolved after approximately 30 minutes from the event start. No follow-up attempts are needed. No further information is expected.

Other Meds: CLARITIN [GLICLAZIDE]; SYNTHROID; BUSPIRONE; BUPROPION; LISINOPRID

Current Illness:

ID: 1650245
Sex: F
Age:
State: GA

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: fever; Chills; aches/soreness; ear pain; headache; sick stomach; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: Ew0162) via an unspecified route of administration in the left arm on 13Apr2021 at 11:30(at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), melatonin (MANUFACTURER UNKNOWN) and loratadine (CLARITIN) for an unknown indication from an unknown date. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: En6204) via an unspecified route of administration in the left arm on 24Mar2021 at 14:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 12:00am, the patient reported that after 12 hours symptoms started. On 14Apr2021 at 12:00am, the patient experienced chills, aches, soreness, ear pain, headache and sick stomach. On 14Apr2021 at 03:00, the patient experienced fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events fever, chills, aches, soreness, ear pain, headache and sick stomach was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADDERALL; MELATONIN; CLARITIN [LORATADINE]

Current Illness:

ID: 1650246
Sex: F
Age:
State: CT

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Very painful, very enlarged lymphnode in left armpit.; Very painful, very enlarged lymph node in left armpit.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 17:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have allergies to medications, food, or other products. Concomitant medication included neora fit supplements from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Apr2021 at 10:00, the patient experienced very painful and very enlarged lymph node in left armpit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the events very painful and very enlarged lymph node in left armpit was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650247
Sex: F
Age:
State: FL

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Fever; Chills; body aches; swollen lymph node under left arm; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration in the left arm on 14Apr2021 at 12:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation.The patient had no medical history. The patient did not receive any medications within two weeks of vaccination. The patient previously received DITROPAN for unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 24Mar2021 at 12:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 04:00, the patient experienced fever, chills, body aches and swollen lymph node under left arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcomes of the events fever, chills, body aches and swollen lymph node under left arm were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650248
Sex: F
Age:
State: NC

Vax Date: 04/08/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Since the 2nd dose of the pfizer vaccine, the patient vision had changed; The patient cannot see the prescription through eyeglasses, and had trouble reading up close material, it was blurry; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 12:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus and blood pressure high. It was unknown whether the patient had allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN); pioglitazone (MANUFACTURER UNKNOWN); acetylsalicylic acid (BAYER ASPIRIN); iron (MANUFACTURER UNKNOWN); HYDR; all were taken for unspecified indication since unspecified date within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 10:00, since the 2nd dose of the Pfizer vaccine, the patient vision had changed, the patient cannot see the prescription through eyeglasses, and had trouble reading up close material, it was blurry. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vision had changed since the 2nd dose of the Pfizer vaccine, the patient cannot see the prescription through eyeglasses and had trouble reading up close material and it was blurry were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: METFORMIN; PIOGLITAZONE; BAYER ASPIRIN; IRON

Current Illness:

ID: 1650249
Sex: M
Age:
State: VA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210414; Test Name: Heart rate; Result Unstructured Data: Test Result:85 Units:{DF}; Comments: 85bpm Heart rate of 85 bpm for seven hours

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Heart rate of 85 bpm for seven hours; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 11:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient did not have any allergies to food, medications and other products. Concomitant medications taken within two weeks of vaccination included atorvastatin calcium (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 22:00, the patient experienced heart rate of 85 beats per minute for seven hours. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event heart rate of 85 beats per minute for seven hours was resolved on 15Apr2021 at 05:00. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ATORVASTATIN CALCIUM

Current Illness:

ID: 1650250
Sex: F
Age:
State: IN

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Heartburn; Nauseous; Headache; Painful arm that was expected; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 18:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. Prior vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 07:00, the patient was nauseous with heartburn, accompanied by headache and the patient expected painful arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of events nauseous, heartburn, headache and painful arm that was expected was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650251
Sex: F
Age:
State: VA

Vax Date: 04/09/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Pain and swelling of lymph nodeabove collarbone; swelling of lymph node above collarbone; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 16:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had reported no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), fexofenadine hydrochloride (ALLEGRA) bupropion hydrochloride (WELLBUTRIN) all were from unknown date and for unspecified indication, and unknown medication from unknown date for birth control. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 17:00, noticed onset 6 days after injection, the patient experienced pain and swelling of lymph node above collarbone on the same side as the injection. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain and swelling of lymph node above collarbone on the same side as the injection was not recovered at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ADDERALL; ALLEGRA; WELLBUTRIN

Current Illness:

ID: 1650252
Sex: F
Age:
State: FL

Vax Date: 03/25/2021
Onset Date: 03/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Cat scan; Result Unstructured Data: Test Result:Unknown result

Allergies:

Symptom List: Nausea

Symptoms: Two days after first dose of vaccine, the patient started horrific debilitating migraines with aura which was not having prior to shot.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8730) via an unspecified route of administration in the left arm on 25Mar2021 at 10:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included methylenetetrahydrofolate reductase gene mutation (MTHFR), prothrombin III, factor II, hypertension, anxiety, asthma and gastroesophageal reflux disease (GERD). The patient previously took (LEVAQUIN) for unknown indication since an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) and buspirone hydrochloride (MANUFACTURER UNKNOWN); both were taken for unknown indication since unknown date within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, two days after first dose of vaccine, the patient started horrific debilitating migraines with aura which was not there prior to shot. They continued daily (multiple times) for 3 weeks after. The event resulted in doctor or other healthcare professional office/clinic visit (neurologist visit). Therapeutic measures were taken as a result of the event and included treatment with unknown medication from an unknown date in 2021. On an unknown date the patient underwent computerized tomogram (CAT) scan and the result was unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event two days after first dose of vaccine, the patient started horrific debilitating migraines with aura which was not having prior to shot was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROCHLOROTHIAZIDE; BUSPIRONE HYDROCHLORIDE

Current Illness:

ID: 1650253
Sex: F
Age:
State: WI

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: fever; some pain in underarm of left arm; chills; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0169) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history includes COVID-19 and allergies to adhesive on lg bandaids. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), apoaequorin (PREVAGEN) and zinc (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if onging. The patient previously received chlorhexidine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 14:00, the patient experienced fever and chills. some pain in underarm of left arm. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, some pain in underarm of left arm and chills were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; CALCIUM; PREVAGEN [APOAEQUORIN]; ZINC

Current Illness:

ID: 1650254
Sex: F
Age:
State: PA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: The left side of face is numb; tingling from the corner of mouth to the top of my cheek.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) via an unspecified route of administration in the left arm on 14Apr2021 at 09:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient was allergic to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (TYLENOL) for an unknown indication and on occasion. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 18:00, the patient experienced left side of her face was numb and tingling from the corner of her mouth to the top of her cheek. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events left side of her face was numb and tingling from the corner of her mouth to the top of her cheek was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL

Current Illness:

ID: 1650255
Sex: F
Age:
State: VA

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: terrible brain fog; Loss of short term memory.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included protein s deficiency, factor v leiden mutation, mthfr gene mutation, migraine and deep vein thrombosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included apixaban (ELIQUIS) and fremanezumab vfrm (AJOVY) from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced terrible brain fog and loss of short-term memory. No therapeutic measures were taken as a result of the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome for the events confused and short-term memory loss were not recovered at the time of the report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: ELIQUIS; AJOVY [FREMANEZUMAB VFRM]

Current Illness:

ID: 1650256
Sex: M
Age:
State: CT

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210414; Test Name: Body temperature; Result Unstructured Data: Test Result:101; Comments: test time: 21:00

Allergies:

Symptom List: Tremor

Symptoms: Coughing; Body aches; Fever of 101; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) received from an unknown date for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 21:00, the patient experienced body aches, fever of 101, headache, fatigue and coughing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body aches, fever of 101, headache, fatigue and coughing was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1650257
Sex: F
Age:
State: VA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Charlie horses and cramping on left side of my body especially in left thigh. Started 20 min after.; Charlie horses and cramping on left side of my body especially in left thigh. Started 20 min after.; But by 8pm I was tired.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 14:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included slight nerve damage and allergic to mangoes. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN) 25mg daily for an unknown indication from an unknown date. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 14:30 the patient experienced Charlie horses and cramping on left side of the body especially in left thigh, which started 20 min after. It went away in the evening of the day the patient got the shot, but by 8pm was tired. The patient felt okay the morning of reporting but by evening had intense Charlie horsing on the left side again and even into the arm and back. The patient was told to go to the ER at the onsite vaccine aftercare if she still had cramping continuing later. So, the patient would probably call the doctor then go. The patient was not really sure what to do, as Charlie horses were not normal and it was making her nervous. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the event Charlie horses, cramping on left side of the body especially in left thigh and tired were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMITRIPTYLINE

Current Illness:

ID: 1650258
Sex: F
Age:
State: AZ

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:101.7 Units:{DF}

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: 101.7 temperature; Swelling of face; joint pain; muscle pain; headache; chills; tired; lump in injection spot; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO150) via an unspecified route of administration in the right arm on 13Apr2021 at 21:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis, blood pressure high and allergies. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 the patient experienced 101.7 temperature, swelling of face, joint pain, muscle pain, headache, chills, tired and lump in injection spot. The patient called doctor and was waiting to hear from them. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent body temperature and the result was 101.7 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event 101.7 temperature. swelling of face, joint pain, muscle pain, headache, chills, tired, lump in injection spot was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650259
Sex: F
Age:
State: MD

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Swollen lymph node in armpit and painful; Fever; Chills; Achy joints; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Apr2021 at 09:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 18May2021 at 13:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 10:00 the patient experienced swollen lymph node in arm pit, painful, fever, chills and achy joints. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, achy joints, swollen lymph node in arm pit and painful were recovered on unspecified date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650260
Sex: F
Age:
State: GA

Vax Date: 03/02/2021
Onset Date: 03/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Chills; Aching; Nausea; Diarrhea; Weakness; This is a spontaneous report from a non-contactable consumer, the patient. A 71-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the right arm on 02Mar2021 at 09:30 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included COVID-19. The patient did not have any known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 23Mar2021, the patient experienced chills, aching, nausea, diarrhea and weakness. Since the vaccination, the patient had not been tested for COVID-19. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome for the events chills, aching, nausea, diarrhea and weakness were resolved on an unspecified date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650261
Sex: F
Age:
State: MA

Vax Date: 04/07/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210413; Test Name: Heart Rate; Result Unstructured Data: Test Result:normal; Test Date: 202104; Test Name: Heart Rate; Result Unstructured Data: Test Result:varied between 80 -90 bpm for 48 hours; Test Date: 20210410; Test Name: Heart Rate; Result Unstructured Data: Test Result:over 90 bpm; Comments: At 01:00

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Resting heart rate over 90 bpm; Woke up at night; Felt like had drank several highly caffeinated beverages; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, postpartum depression and seasonal allergies. Concomitant medications included loratadine (CLARITIN), fluoxetine (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknow if ongoing. The patient previously took sulfamethoxazole, trimethoprim, (BACTRIM) from an unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021 at 01:00, the patient experienced resting heart rate over 90 bpm (beats per minute), woke her up at night and would not decrease for several hours, it felt like she had drunk several highly caffeinated beverages. RHR (rapid heart rate) varied between 80 - 90 bpm (beats per minute) for 48 hours, then returned to normal after 72 hours. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event resting heart rate over 90 bpm was resolved on 13Apr2021 at 01:00 (after the duration of 72 hours), events woke up at night felt like had drank several highly caffeinated beverages were resolved on an unspecified date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: CLARITINE; FLUOXETINE; LEVOTHYROXINE

Current Illness:

ID: 1650262
Sex: M
Age:
State: CA

Vax Date: 04/04/2021
Onset Date: 04/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Lymph nodes inarmpit of arm that was injected became tender about 2 days postinjection and stayed tender for another 5 days.; Local pain, and swelling at injectionsite starting day after injection andlasting about 4 days.; Local pain, and swelling at injectionsite starting day after injection andlasting about 4 days.; Headache that lasted for about 3 days, starting about 30 min post injection.; Feeling unwell (flu-like symtpoms) for about 36 hours.; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 04Apr2021 at 09:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included kidney stones. Concomitant medications included allopurinol (MANUFACTURER UNKNOWN) indicated for kidney stones from unspecified date. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 14Mar2021 at 09:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 10:15, 30 minutes post injection, the patient experienced headache and felt unwell (flu-like symptoms). On 05Apr2021, the patient experienced local pain and swelling at injection site. On 06Apr2021, the patient felt that lymph nodes in armpit of arm that was injected became tender about 2 days post injection. No therapeutic measures were taken as a result of these events. These events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event headache was recovered on 07Apr2021, after the duration of about 3 days. The clinical outcome of the event flu-like symptoms was recovered, after the duration of 36 hours. The clinical outcome of the events local pain and swelling at injection site was recovered on 09Apr2021, after the duration of about 4 days. The clinical outcome of the event tender lymph nodes was recovered on 11Apr2021, after the duration of 5 days. No follow-up attempts are possible. No further information is expected

Other Meds: ALLOPURINOL

Current Illness:

ID: 1650263
Sex: F
Age:
State: FL

Vax Date: 04/01/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Shingles in the lower back.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 14:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to food, medication and other products. On 08Apr2021 at 09:00, the patient experienced shingles in the lower back and the patient never experienced shingles or herpes and did not had sexual relationships. The patient was healthy and did not take any medications. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with antibiotic cream (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles in the lower back was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650264
Sex: F
Age:
State: CA

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Date: 20210401; Test Name: Routine blood test; Result Unstructured Data: Test Result:8.22 (UNIT UNSPECIFIED); Comments: TSH result was 8.22

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Left thyroid gland is somewhatenlarged.; TSH result increased; pain at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Feb2021 (at the age of 79-year-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation paroxysmal and cardiac ablation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient had no allergies to medications, food, or other products. Concomitant medications included estradiol (MANUFACTURER UNKNOWN) 0.375 mg and progesterone (MANUFACTURER UNKNOWN) 100 mg daily, both for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Feb2021 at 08:00 (at the age of 79-year-old) as a single dose for COVID-19 immunisation and patient experienced vaccination site pain. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient underwent routine blood test and the result was 8.22 an unspecified unit. On 27Feb2021 the patient experienced pain at the injection site. Therapeutic measures were taken for the reported events of pain at the injection site and treatment are gentle massage. On 01Apr2021 the patient experienced TSH result increased (8.22). On 14Apr2021 the patient experienced left thyroid gland enlarged. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the event of pain at the injection site was recovered on 27Feb2021 at the time of one day duration. The clinical outcome of the events of TSH result increased and left thyroid gland enlarged was not recovered at the time of this report No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ESTRADIOL; PROGESTERONE

Current Illness:

ID: 1650265
Sex: M
Age:
State: NJ

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Numbness on left arm (injection arm, spreading to left hand); This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 16:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021, the patient experienced numbness on left arm (injection arm, spreading to left hand). The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event numbness on left arm (injection arm, spreading to left hand) was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650266
Sex: M
Age:
State: PA

Vax Date: 04/11/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Aches; Chills; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 17:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no allergies to food, medications or other products. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR), fluoxetine hydrochloride (PROZAC), cetirizine hydrochloride (ZYRTEC) and fluticasone propionate (FLONASE) all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 11:30, the patient experienced aches and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of aches and chills and included treatment with ibuprofen (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events aches and chills was recovered on an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ADVAIR; PROZAC; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1650267
Sex: M
Age:
State: MA

Vax Date:
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210413; Test Name: body temperature; Result Unstructured Data: Test Result:above 102

Allergies:

Symptom List: Vomiting

Symptoms: Full body pain; fever above 102; This is a spontaneous report from a contactable consumer. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date ( at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have any allergies to food, medications and other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Apr2021, the patient experienced full body pain and fever. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 13Apr2021, the patient underwent body temperature test and the result was above 102. The clinical outcome of the event full body pain, fever was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650268
Sex: U
Age:
State:

Vax Date:
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Swollen armpit; This is a spontaneous report from a non-contactable consumer. A patient of unknown age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021, the patient experienced swollen armpit. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the event swollen armpit was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650269
Sex: F
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: itchy rash all over body; Red, itchy rash all over body; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0510), via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot number: ER2631), via an unspecified route of administration in the left arm on 19Mar2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced red, itchy rash all over body. No therapeutic measures were taken as a result of the adverse events. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event red, itchy rash all over body was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650270
Sex: F
Age:
State: CA

Vax Date: 04/13/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Itchy Rash all over back, head, arms, neck, and stomach; Looks like hives covering entire body; Shaky; Weak; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0151) via an unspecified route of administration in the arm left on 13Apr2021 at 11:00 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 23Mar2021 at 11:00 (at the age of 24-year-old)as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 12:00, the patient experienced itchy rash all over back, head, arms, neck and stomach (looked like hives covering entire body), shaky and weak. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events itchy rash all over back, head, arms, neck and stomach, looked like hives, shaking and weakness was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650271
Sex: M
Age:
State: NC

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Intense ringing in right ear lasting a minute.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 12Apr2021 at 13:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had no known drug allergy. Concomitant medications included men's perfect multi (PURITY PRODUCTS), glucosamine; chondroitin sulfate (GC FLEX) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 07:45, the patient experienced intense ringing in right ear lasting a minute. Then subsided to a sustained ringing with sporadic intense bouts. Right ear continued to ring all day. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event intense ringing in right ear lasting a minute was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650272
Sex: M
Age:
State: GA

Vax Date: 04/02/2021
Onset Date: 04/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: PCR; Test Result: Negative

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Vertigo; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration on 02Apr2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as N/A. The patient did not have any allergies to food, medications, or other products. Concomitant medication included paracetamol (TYLENOL) for an unknown indication on an unspecified date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the left arm on 12Mar2021 at 11:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 08:00, the patient experienced vertigo and dizziness. The patient had been feeling dizzy since then. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. On an unknown date patient underwent lab test which included PCR test for COVID-19 and tested negative. No therapeutic measures were taken as a result of the events. The clinical outcome of the events vertigo and dizziness were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am